Processing

Please wait...

Settings

Settings

Goto Application

1. WO2006129178 - NOVEL CANNABINOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESS FOR THEIR PREPARATION

Publication Number WO/2006/129178
Publication Date 07.12.2006
International Application No. PCT/IB2006/001437
International Filing Date 01.06.2006
IPC
C07D 231/54 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
231Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
54condensed with carbocyclic rings or ring systems
A61K 31/416 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
4151,2-Diazoles
416condensed with carbocyclic ring systems, e.g. indazole
CPC
A61P 1/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
A61P 1/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
04for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
A61P 1/08
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
08for nausea, cinetosis or vertigo; Antiemetics
A61P 1/14
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
A61P 1/16
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
16for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
A61P 11/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
11Drugs for disorders of the respiratory system
Applicants
  • GLENMARK PHARMACEUTICALS S.A. [CH]/[CH] (AllExceptUS)
  • MUTHUPPALANIAPPAN, Meyyappan [IN]/[IN] (UsOnly)
  • BALASUBRAMANIAN, Gopalan [IN]/[IN] (UsOnly)
  • GULLAPALLI, Srinivas [IN]/[IN] (UsOnly)
  • JOSHI, Neelima, Khairatkar [IN]/[IN] (UsOnly)
  • NARAYANAN, Shridhar [IN]/[IN] (UsOnly)
Inventors
  • MUTHUPPALANIAPPAN, Meyyappan
  • BALASUBRAMANIAN, Gopalan
  • GULLAPALLI, Srinivas
  • JOSHI, Neelima, Khairatkar
  • NARAYANAN, Shridhar
Priority Data
1370/MUM/200531.10.2005IN
344/MUM/200609.03.2006IN
60/696,43301.07.2005US
60/744,07131.03.2006US
659/MUM/200502.06.2005IN
689/MUM/200603.05.2006IN
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) NOVEL CANNABINOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESS FOR THEIR PREPARATION
(FR) NOUVEAUX LIGANDS DES RECEPTEURS DES CANNABINOIDES, COMPOSITIONS PHARMACEUTIQUES CONTENANT CES LIGANDS, ET PROCEDE SERVANT A LEUR PREPARATION
Abstract
(EN)
The present invention relates to novel cannabinoid receptor modulators, in particular cannabinoid 1 (CBl) or cannabinoid 2 (CB2) receptor modulators, and uses thereof for treating diseases, conditions and/or disorders modulated by a cannabinoid receptor (such as pain, neurodegenative disorders, eating disorders, weight loss or control, and obesity).
(FR)
Cette invention concerne de nouveaux modulateurs des récepteurs des cannabinoïdes, en particulier des modulateurs du récepteur 1 (CB1) ou du récepteur 2 (CB2) des cannabinoïdes, et des utilisations de ces modulateurs pour traiter des maladies, des états et/ou des troubles modulés par un récepteur des cannabinoïdes (tels que la douleur, les troubles neurodégénératifs, les troubles de l'alimentation, la perte ou le contrôle du poids et l'obésité).
Latest bibliographic data on file with the International Bureau